Orchard Therapeutics PLC (NASDAQ:ORTX)
| 2.90 BATS BZX Real-Time Price As of 3:38pm ET |  0.00 / 0.00%Today’s Change | 2.32 Today|||52-Week Range 9.08 | -32.87% Year-to-Date |
Latest ORTX News | Press Releases
No recent news for Orchard Therapeutics PLC.
Today’s Trading
| Previous close | 2.90 |
| Today’s open | 2.88 |
| Day’s range | 2.90 - 2.92 |
| Volume | 9,958 |
| Average volume (3 months) | 579,266 |
| Market cap | $319.8M |
Data as of 3:38pm ET, 09/16/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +4.07% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| ---- | ||
| AMPEAmpio Pharmaceutical... | -0.01 | -0.88% |
| THTXTheratechnologies In... | 0.00 | 0.00% |
| NLTXNeoleukin Therapeuti... | -0.04 | -0.50% |
Data as of 3:52pm ET, 09/16/2021
Financials
| Next reporting date | November 10, 2021 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $2.6M |
| Annual profit (last year) | -$153.2M |
| Net profit margin | -5,856.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
